• Man Luo, Jing Lıu, Yeshuang Yuan, Yong Chen, and Guohua Yuan.
• Division of Rheumatology, Department of Internal Medicine, Suining Central Hospital, Sichuan, China ; Division of Institute Rheumatology, Department of Internal Medicine, Faculty of Medicine, Affiliated Hospital of North Sichuan Medical College, Sichuan, China.
• Turk J Med Sci. 2022 Aug 1; 52 (4): 984989984-989.

BackgroundTo measure the expression of 1α-hydroxylase (CYP27B1) and serum 25(OH)D concentration in systemic lupus erythematosus (SLE) and to investigate the role of CYP27B1 in SLE.MethodsSeventy-seven SLE patients and 35 healthy controls (HCs) were enrolled from September 2017 to January 2020. The study design is cross-sectional. mRNA expression of CYP27B1 in peripheral blood mononuclear cells (PBMCs) was measured by reverse-transcription quantitative PCR, the protein level of CYP27B1 was quantified by western blotting, and the serum level of 25(OH) D was determined by an enzyme-linked immunosorbent assay.ResultsThe mRNA expression of CYP27B1 in PBMCs was significantly lower in SLE patients than in HCs (p < 0.001), and the protein quantification confirmed that CYP27B1 expression was lower in SLE patients than in HCs (p = 0.001). Among SLE patients, the prevalence of lupus nephritis was higher in a subgroup with lower CYP27B1 mRNA expression than in a subgroup with normal CYP27B1 mRNA expression (41.07% vs. 14.28%, p = 0.028). The mRNA expression of CYP27B1 negatively correlated with the Systemic Lupus Erythematosus Disease Activity Index (r = -0.331, p = 0.003). Serum 25(OH)D concentration was lower in SLE patients than in HCs (37.64 ± 19.89 vs. 50.58 ± 12.74 ng/mL, mean ± SD, p = 0.003).DiscussionThe expression of CYP27B1 in PBMCs may be related to SLE pathogenesis, disease activity, and nephritis.

16 keywords...

hide…